Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001439222-24-000061
Filing Date
2024-03-11
Accepted
2024-03-11 16:09:27
Documents
1
Period of Report
2024-03-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1710187757.html 4  
1 FORM 4 wk-form4_1710187757.xml 4 3738
  Complete submission text file 0001439222-24-000061.txt   5274
Mailing Address JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Business Address
Foster-Cheek Kaye I (Reporting) CIK: 0001312622 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36014 | Film No.: 24738054

Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Issuer) CIK: 0001439222 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)